Rockwell Medical Receives Japanese Patent Issuance for Triferic(TM) GMP Formulation

Rockwell Medical, Inc. (NASDAQ: RMTI ), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for ...



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1f2D0Eh

via IFTTT